Caseware UK (AP4) 2023.0.135 2023.0.135 2024-09-302024-09-30falsefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2023-10-01false0true0 02543120 2023-10-01 2024-09-30 02543120 2022-10-01 2023-09-30 02543120 2024-09-30 02543120 2023-09-30 02543120 c:Director1 2023-10-01 2024-09-30 02543120 d:CurrentFinancialInstruments 2024-09-30 02543120 d:CurrentFinancialInstruments 2023-09-30 02543120 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 02543120 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 02543120 d:ShareCapital 2024-09-30 02543120 d:ShareCapital 2023-09-30 02543120 d:SharePremium 2024-09-30 02543120 d:SharePremium 2023-09-30 02543120 d:CapitalRedemptionReserve 2024-09-30 02543120 d:CapitalRedemptionReserve 2023-09-30 02543120 d:RetainedEarningsAccumulatedLosses 2024-09-30 02543120 d:RetainedEarningsAccumulatedLosses 2023-09-30 02543120 c:OrdinaryShareClass1 2023-10-01 2024-09-30 02543120 c:OrdinaryShareClass1 2024-09-30 02543120 c:OrdinaryShareClass1 2023-09-30 02543120 c:FRS102 2023-10-01 2024-09-30 02543120 c:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 02543120 c:FullAccounts 2023-10-01 2024-09-30 02543120 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 02543120 2 2023-10-01 2024-09-30 02543120 6 2023-10-01 2024-09-30 02543120 e:PoundSterling 2023-10-01 2024-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 02543120









NIMROD LIFE SCIENCES LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2024

 
NIMROD LIFE SCIENCES LIMITED
REGISTERED NUMBER: 02543120

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

FIXED ASSETS
  

Investments
 4 
243,418
243,418

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
137,381
44,379

Cash at bank and in hand
  
470,130
603,026

  
607,511
647,405

Creditors: amounts falling due within one year
 6 
(2,400)
(2,230)

NET CURRENT ASSETS
  
 
 
605,111
 
 
645,175

  

NET ASSETS
  
848,529
888,593


CAPITAL AND RESERVES
  

Called up share capital 
 7 
4
4

Share premium account
  
109,409
109,409

Capital redemption reserve
  
4
4

Profit and loss account
  
739,112
779,176

  
848,529
888,593


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Page 1

 
NIMROD LIFE SCIENCES LIMITED
REGISTERED NUMBER: 02543120
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2024

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr M J M Rawe
Director

Date: 5 February 2025

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


GENERAL INFORMATION

Nimrod Life Sciences Limited is limited by shares and incorporated in England and Wales. Its registered office is Unit 1, Priors Hall, Widdington, Saffron Walden, Essex, CB11 3SB. The company's functional and presentational currency is GBP and the figures in these financial statements are rounded to the nearest pound.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

INTEREST INCOME

Interest income is recognised in profit or loss using the effective interest method.

 
2.3

PENSIONS

The company contributes to the personal pension plan of the director.
The contributions are recognised as an expense in the Profit and Loss Account when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of this plan are held separately from the Company in independently administered funds.

 
2.4

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.5

VALUATION OF INVESTMENTS

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.6

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.ACCOUNTING POLICIES (CONTINUED)

 
2.7

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


EMPLOYEES

The company has no employees other than a director, who received contributions into their pension plan of £60,000 (2023 - £100,000).


4.


FIXED ASSET INVESTMENTS





Investments in subsidiary companies

£



COST OR VALUATION


At 1 October 2023
243,418



At 30 September 2024
243,418







5.


DEBTORS

2024
2023
£
£


Amounts owed by group undertakings
134,547
44,379

Other debtors
2,834
-

137,381
44,379


Page 4

 
NIMROD LIFE SCIENCES LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024
2023
£
£

Accruals and deferred income
2,400
2,230



7.


SHARE CAPITAL

2024
2023
£
£
ALLOTTED, CALLED UP AND FULLY PAID



4 (2023 - 4) Ordinary shares of £1.00 each
4
4


 
Page 5